Started Apr 09, 2019 05:47PM UTC   •   Closed Apr 23, 2019 07:45PM UTC (4 months ago)

Will AbbVie's new psoriasis drug Skyrizi (approved in Japan) receive U.S. Food and Drug Administration approval by 30 June 2019?

Tags
Challenges
Resolution Notes
Received FDA approval by April 23, 2019. https://news.abbvie.com/news/press-releases/abbvie-expands-immunology-portfolio-in-us-with-fda-approval-skyrizi-risankizumab-rzaa-for-moderate-to-severe-plaque-psoriasis.htm
Last Updated 24/08/19 08:45am

Final Crowd Forecast

100%

Chance

No. of Forecasts
You've Made

0

No. of
Forecasters

2

Forecast
Count

2

Final Results

1.
₡1,680
2.
₡348

Most Accurate

Score

1.
1 points
2.
-1 points